Amorphization of poorly water soluble drugs is useful in terms of the improvement of dissolution rate and bioavailability because amorphous compounds possess higher energy than their crystalline forms. 1,2) On the other hand, amorphous compounds are thermodynamically unstable and may crystallize during storage. [3][4][5] Owing to the physical instability of amorphous compounds, product development and regulatory approval may become difficult unless it can be demonstrated that conversion to the crystalline state during handling and storage periods will not occur. 6) Although the storage experiments are conducted to predict the stability of amorphous compounds, this is a time-and material-consuming method.
7)Therefore, it is preferable to be able to evaluate the physical stability of amorphous compounds more easily.Amorphous compounds change their physical and thermodynamic characteristics until they reach a metastable state.
8)As freshly prepared amorphous compounds move toward a more equilibrium state, energy decreases, free volume decreases, and structural order increases.9,10) This process is known as structural relaxation. Many studies used structural relaxation time as an indicator of molecular mobility.
11)Bhugra et al. reported that crystallization onset times measured above the glass transition temperature (T g ) were well correlated with the relaxation time.12) On the other hand, it was reported that predictions of stability can not be made based on mobility alone, although relaxation time is one of the most important factors involved in the recrystallization process.7,13) When the molecular mobility was focused on, the molecular weight showed the inverse relationship with mobility.14)The molecule at the surface of amorphous compounds has enhanced molecular mobility. [15][16][17] In addition, the surface of amorphous compounds is thought to be easily affected by the external environment such as humidity and temperature. It was reported that crystallization at the amorphous surface was faster than that of the bulk. 18,19) The surface affects crystal nucleation and the rate of crystal growth. 19) This implied that an amorphous surface and the bulk may show different properties. It is important to evaluate properties at the surface in terms of physical stability of amorphous compounds.
20)Inverse gas chromatography (iGC) is becoming popular in the pharmaceutical sector.21) Many studies using iGC have been reported. [22][23][24] Planinšek et al. reported that the surface amorphization rate of indomethacin during milling evaluated by surface energy using iGC, was higher than that of bulk evaluated by crystallization enthalpy and temperature using differential scanning calorimetry (DSC). 25) This means that iGC seems suitable for the characterization of surface properties.Troglitazone, used as the model drug in this study, has two asymmetric carbons and the drug substance is produced as a mixture of equal amounts of four isomers. These isomers are composed of two diastereomer-pairs, RR/SS and RS/SR, which have...